Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-02 · accession 0001348362-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-03 | 2024-12-02+ | LEXX | CHRISTOPHER RICHARD | CEO | P - Purchase | $2.36 | +50.0K | 22.8K | New | +$118.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2024-12-03 | P | A | 27,172 | $2.47 | 50,000 | D | — | — | |
| 2 | Common | common shares | 2024-12-02 | P | A | 22,828 | $2.24 | 22,828 | D | — | — |